Nicolas Pierre

Liege, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials.

International consensus on intestinal epithelial barrier assessment and therapeutic effects in inflammatory bowel diseases clinical trials.

Journal: Gut

Published: April 12, 2026

Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review.

Tools and advanced imaging technologies for assessing intestinal epithelial barrier integrity: a systematic review.

Journal: American journal of physiology. Gastrointestinal and liver physiology

Published: February 12, 2026

Higher humoral response in ileal versus colonic Crohn's disease.

Higher humoral response in ileal versus colonic Crohn's disease.

Journal: Clinical and experimental immunology

Published: March 14, 2025

External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.

External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.

Journal: Gut

Published: April 12, 2024

Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease.

Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease.

Journal: Journal of proteomics

Published: March 08, 2024

Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn's disease.

Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn's disease.

Journal: Scandinavian journal of gastroenterology

Published: February 27, 2024

Defining Biological Remission in Crohn's Disease: Interest, Challenges and Future Directions.

Defining Biological Remission in Crohn's Disease: Interest, Challenges and Future Directions.

Journal: Journal of Crohn's & colitis

Published: May 19, 2023

Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.

Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.

Journal: Gut

Published: March 08, 2022

Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.

Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.

Journal: Journal of Crohn's & colitis

Published: April 06, 2021

Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology.

Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology.

Journal: Alimentary pharmacology & therapeutics

Published: March 27, 2021

Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study.

Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study.

Journal: Gut

Published: June 10, 2020

The pharmacologic characterization of allosteric molecules: Gq protein activation.

The pharmacologic characterization of allosteric molecules: Gq protein activation.

Journal: Journal of receptor and signal transduction research

Published: July 20, 2019

Showing 1-12 of 26

Last Updated: 09/26/2026